药品合同生产组织(颁惭翱)是一种新兴外包服务模式,主要接受制药公司的委托,为其提供生产工艺的开发、改进服务以及临床试验和商业化销售药物所用中间体、原料药、制剂的生产供应服务。
Market Analysis and Insights: Global Contract Bio-manufacturing Organization (CMO) Market
The global Contract Bio-manufacturing Organization (CMO) market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers:
This report presents an overview of global market for Contract Bio-manufacturing Organization (CMO) market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Contract Bio-manufacturing Organization (CMO), also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Contract Bio-manufacturing Organization (CMO), and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Contract Bio-manufacturing Organization (CMO) revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Contract Bio-manufacturing Organization (CMO) market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Contract Bio-manufacturing Organization (CMO) revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
Abzena
Althea
Asymchem Laboratories Inc.
Baxter Biopharma Solutions
Biomeva
Boehringer Ingelheim
Celltrion
AGC Biologics
Cytovance Biologics
Fujifilm Diosynth Technologies
KBI Biopharma
Lonza Group
MicroProtein Technologies
Patheon
Porton Pharma Solutions
Probiogen
Rader
Rentschler Biotechnologie
Samsung
Sandoz
STA Pharmaceutical Co. Ltd
Segment by Type
Big Bio/Pharma Type
Small/Med Bio/Pharma Type
Virtual/Emerging Type
Segment by Application
Pharmaceutical Industry
Biotechnology
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Contract Bio-manufacturing Organization (CMO) in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Contract Bio-manufacturing Organization (CMO) companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Contract Bio-manufacturing Organization (CMO) revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Contract Bio-manufacturing Organization (CMO) Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Big Bio/Pharma Type
1.2.3 Small/Med Bio/Pharma Type
1.2.4 Virtual/Emerging Type
1.3 Market by Application
1.3.1 Global Contract Bio-manufacturing Organization (CMO) Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Pharmaceutical Industry
1.3.3 Biotechnology
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Contract Bio-manufacturing Organization (CMO) Market Perspective (2019-2030)
2.2 Global Contract Bio-manufacturing Organization (CMO) Growth Trends by Region
2.2.1 Contract Bio-manufacturing Organization (CMO) Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Contract Bio-manufacturing Organization (CMO) Historic Market Size by Region (2019-2024)
2.2.3 Contract Bio-manufacturing Organization (CMO) Forecasted Market Size by Region (2025-2030)
2.3 Contract Bio-manufacturing Organization (CMO) Market Dynamics
2.3.1 Contract Bio-manufacturing Organization (CMO) Industry Trends
2.3.2 Contract Bio-manufacturing Organization (CMO) Market Drivers
2.3.3 Contract Bio-manufacturing Organization (CMO) Market Challenges
2.3.4 Contract Bio-manufacturing Organization (CMO) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Contract Bio-manufacturing Organization (CMO) by Players
3.1.1 Global Contract Bio-manufacturing Organization (CMO) Revenue by Players (2019-2024)
3.1.2 Global Contract Bio-manufacturing Organization (CMO) Revenue Market Share by Players (2019-2024)
3.2 Global Contract Bio-manufacturing Organization (CMO) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Contract Bio-manufacturing Organization (CMO), Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Contract Bio-manufacturing Organization (CMO) Market Concentration Ratio
3.4.1 Global Contract Bio-manufacturing Organization (CMO) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Contract Bio-manufacturing Organization (CMO) Revenue in 2023
3.5 Global Key Players of Contract Bio-manufacturing Organization (CMO) Head office and Area Served
3.6 Global Key Players of Contract Bio-manufacturing Organization (CMO), Product and Application
3.7 Global Key Players of Contract Bio-manufacturing Organization (CMO), Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Contract Bio-manufacturing Organization (CMO) Breakdown Data by Type
4.1 Global Contract Bio-manufacturing Organization (CMO) Historic Market Size by Type (2019-2024)
4.2 Global Contract Bio-manufacturing Organization (CMO) Forecasted Market Size by Type (2025-2030)
5 Contract Bio-manufacturing Organization (CMO) Breakdown Data by Application
5.1 Global Contract Bio-manufacturing Organization (CMO) Historic Market Size by Application (2019-2024)
5.2 Global Contract Bio-manufacturing Organization (CMO) Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Contract Bio-manufacturing Organization (CMO) Market Size (2019-2030)
6.2 North America Contract Bio-manufacturing Organization (CMO) Market Size by Type
6.2.1 North America Contract Bio-manufacturing Organization (CMO) Market Size by Type (2019-2024)
6.2.2 North America Contract Bio-manufacturing Organization (CMO) Market Size by Type (2025-2030)
6.2.3 North America Contract Bio-manufacturing Organization (CMO) Market Share by Type (2019-2030)
6.3 North America Contract Bio-manufacturing Organization (CMO) Market Size by Application
6.3.1 North America Contract Bio-manufacturing Organization (CMO) Market Size by Application (2019-2024)
6.3.2 North America Contract Bio-manufacturing Organization (CMO) Market Size by Application (2025-2030)
6.3.3 North America Contract Bio-manufacturing Organization (CMO) Market Share by Application (2019-2030)
6.4 North America Contract Bio-manufacturing Organization (CMO) Market Size by Country
6.4.1 North America Contract Bio-manufacturing Organization (CMO) Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Contract Bio-manufacturing Organization (CMO) Market Size by Country (2019-2024)
6.4.3 North America Contract Bio-manufacturing Organization (CMO) Market Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Contract Bio-manufacturing Organization (CMO) Market Size (2019-2030)
7.2 Europe Contract Bio-manufacturing Organization (CMO) Market Size by Type
7.2.1 Europe Contract Bio-manufacturing Organization (CMO) Market Size by Type (2019-2024)
7.2.2 Europe Contract Bio-manufacturing Organization (CMO) Market Size by Type (2025-2030)
7.2.3 Europe Contract Bio-manufacturing Organization (CMO) Market Share by Type (2019-2030)
7.3 Europe Contract Bio-manufacturing Organization (CMO) Market Size by Application
7.3.1 Europe Contract Bio-manufacturing Organization (CMO) Market Size by Application (2019-2024)
7.3.2 Europe Contract Bio-manufacturing Organization (CMO) Market Size by Application (2025-2030)
7.3.3 Europe Contract Bio-manufacturing Organization (CMO) Market Share by Application (2019-2030)
7.4 Europe Contract Bio-manufacturing Organization (CMO) Market Size by Country
7.4.1 Europe Contract Bio-manufacturing Organization (CMO) Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Contract Bio-manufacturing Organization (CMO) Market Size by Country (2019-2024)
7.4.3 Europe Contract Bio-manufacturing Organization (CMO) Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Contract Bio-manufacturing Organization (CMO) Market Size (2019-2030)
8.2 China Contract Bio-manufacturing Organization (CMO) Market Size by Type
8.2.1 China Contract Bio-manufacturing Organization (CMO) Market Size by Type (2019-2024)
8.2.2 China Contract Bio-manufacturing Organization (CMO) Market Size by Type (2025-2030)
8.2.3 China Contract Bio-manufacturing Organization (CMO) Market Share by Type (2019-2030)
8.3 China Contract Bio-manufacturing Organization (CMO) Market Size by Application
8.3.1 China Contract Bio-manufacturing Organization (CMO) Market Size by Application (2019-2024)
8.3.2 China Contract Bio-manufacturing Organization (CMO) Market Size by Application (2025-2030)
8.3.3 China Contract Bio-manufacturing Organization (CMO) Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Contract Bio-manufacturing Organization (CMO) Market Size (2019-2030)
9.2 Asia Contract Bio-manufacturing Organization (CMO) Market Size by Type
9.2.1 Asia Contract Bio-manufacturing Organization (CMO) Market Size by Type (2019-2024)
9.2.2 Asia Contract Bio-manufacturing Organization (CMO) Market Size by Type (2025-2030)
9.2.3 Asia Contract Bio-manufacturing Organization (CMO) Market Share by Type (2019-2030)
9.3 Asia Contract Bio-manufacturing Organization (CMO) Market Size by Application
9.3.1 Asia Contract Bio-manufacturing Organization (CMO) Market Size by Application (2019-2024)
9.3.2 Asia Contract Bio-manufacturing Organization (CMO) Market Size by Application (2025-2030)
9.3.3 Asia Contract Bio-manufacturing Organization (CMO) Market Share by Application (2019-2030)
9.4 Asia Contract Bio-manufacturing Organization (CMO) Market Size by Region
9.4.1 Asia Contract Bio-manufacturing Organization (CMO) Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Contract Bio-manufacturing Organization (CMO) Market Size by Region (2019-2024)
9.4.3 Asia Contract Bio-manufacturing Organization (CMO) Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Contract Bio-manufacturing Organization (CMO) Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Contract Bio-manufacturing Organization (CMO) Market Size by Type
10.2.1 Middle East, Africa, and Latin America Contract Bio-manufacturing Organization (CMO) Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Contract Bio-manufacturing Organization (CMO) Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Contract Bio-manufacturing Organization (CMO) Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Contract Bio-manufacturing Organization (CMO) Market Size by Application
10.3.1 Middle East, Africa, and Latin America Contract Bio-manufacturing Organization (CMO) Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Contract Bio-manufacturing Organization (CMO) Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Contract Bio-manufacturing Organization (CMO) Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Contract Bio-manufacturing Organization (CMO) Market Size by Country
10.4.1 Middle East, Africa, and Latin America Contract Bio-manufacturing Organization (CMO) Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Contract Bio-manufacturing Organization (CMO) Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Contract Bio-manufacturing Organization (CMO) Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Abzena
11.1.1 Abzena Company Details
11.1.2 Abzena Business Overview
11.1.3 Abzena Contract Bio-manufacturing Organization (CMO) Introduction
11.1.4 Abzena Revenue in Contract Bio-manufacturing Organization (CMO) Business (2019-2024)
11.1.5 Abzena Recent Developments
11.2 Althea
11.2.1 Althea Company Details
11.2.2 Althea Business Overview
11.2.3 Althea Contract Bio-manufacturing Organization (CMO) Introduction
11.2.4 Althea Revenue in Contract Bio-manufacturing Organization (CMO) Business (2019-2024)
11.2.5 Althea Recent Developments
11.3 Asymchem Laboratories Inc.
11.3.1 Asymchem Laboratories Inc. Company Details
11.3.2 Asymchem Laboratories Inc. Business Overview
11.3.3 Asymchem Laboratories Inc. Contract Bio-manufacturing Organization (CMO) Introduction
11.3.4 Asymchem Laboratories Inc. Revenue in Contract Bio-manufacturing Organization (CMO) Business (2019-2024)
11.3.5 Asymchem Laboratories Inc. Recent Developments
11.4 Baxter Biopharma Solutions
11.4.1 Baxter Biopharma Solutions Company Details
11.4.2 Baxter Biopharma Solutions Business Overview
11.4.3 Baxter Biopharma Solutions Contract Bio-manufacturing Organization (CMO) Introduction
11.4.4 Baxter Biopharma Solutions Revenue in Contract Bio-manufacturing Organization (CMO) Business (2019-2024)
11.4.5 Baxter Biopharma Solutions Recent Developments
11.5 Biomeva
11.5.1 Biomeva Company Details
11.5.2 Biomeva Business Overview
11.5.3 Biomeva Contract Bio-manufacturing Organization (CMO) Introduction
11.5.4 Biomeva Revenue in Contract Bio-manufacturing Organization (CMO) Business (2019-2024)
11.5.5 Biomeva Recent Developments
11.6 Boehringer Ingelheim
11.6.1 Boehringer Ingelheim Company Details
11.6.2 Boehringer Ingelheim Business Overview
11.6.3 Boehringer Ingelheim Contract Bio-manufacturing Organization (CMO) Introduction
11.6.4 Boehringer Ingelheim Revenue in Contract Bio-manufacturing Organization (CMO) Business (2019-2024)
11.6.5 Boehringer Ingelheim Recent Developments
11.7 Celltrion
11.7.1 Celltrion Company Details
11.7.2 Celltrion Business Overview
11.7.3 Celltrion Contract Bio-manufacturing Organization (CMO) Introduction
11.7.4 Celltrion Revenue in Contract Bio-manufacturing Organization (CMO) Business (2019-2024)
11.7.5 Celltrion Recent Developments
11.8 AGC Biologics
11.8.1 AGC Biologics Company Details
11.8.2 AGC Biologics Business Overview
11.8.3 AGC Biologics Contract Bio-manufacturing Organization (CMO) Introduction
11.8.4 AGC Biologics Revenue in Contract Bio-manufacturing Organization (CMO) Business (2019-2024)
11.8.5 AGC Biologics Recent Developments
11.9 Cytovance Biologics
11.9.1 Cytovance Biologics Company Details
11.9.2 Cytovance Biologics Business Overview
11.9.3 Cytovance Biologics Contract Bio-manufacturing Organization (CMO) Introduction
11.9.4 Cytovance Biologics Revenue in Contract Bio-manufacturing Organization (CMO) Business (2019-2024)
11.9.5 Cytovance Biologics Recent Developments
11.10 Fujifilm Diosynth Technologies
11.10.1 Fujifilm Diosynth Technologies Company Details
11.10.2 Fujifilm Diosynth Technologies Business Overview
11.10.3 Fujifilm Diosynth Technologies Contract Bio-manufacturing Organization (CMO) Introduction
11.10.4 Fujifilm Diosynth Technologies Revenue in Contract Bio-manufacturing Organization (CMO) Business (2019-2024)
11.10.5 Fujifilm Diosynth Technologies Recent Developments
11.11 KBI Biopharma
11.11.1 KBI Biopharma Company Details
11.11.2 KBI Biopharma Business Overview
11.11.3 KBI Biopharma Contract Bio-manufacturing Organization (CMO) Introduction
11.11.4 KBI Biopharma Revenue in Contract Bio-manufacturing Organization (CMO) Business (2019-2024)
11.11.5 KBI Biopharma Recent Developments
11.12 Lonza Group
11.12.1 Lonza Group Company Details
11.12.2 Lonza Group Business Overview
11.12.3 Lonza Group Contract Bio-manufacturing Organization (CMO) Introduction
11.12.4 Lonza Group Revenue in Contract Bio-manufacturing Organization (CMO) Business (2019-2024)
11.12.5 Lonza Group Recent Developments
11.13 MicroProtein Technologies
11.13.1 MicroProtein Technologies Company Details
11.13.2 MicroProtein Technologies Business Overview
11.13.3 MicroProtein Technologies Contract Bio-manufacturing Organization (CMO) Introduction
11.13.4 MicroProtein Technologies Revenue in Contract Bio-manufacturing Organization (CMO) Business (2019-2024)
11.13.5 MicroProtein Technologies Recent Developments
11.14 Patheon
11.14.1 Patheon Company Details
11.14.2 Patheon Business Overview
11.14.3 Patheon Contract Bio-manufacturing Organization (CMO) Introduction
11.14.4 Patheon Revenue in Contract Bio-manufacturing Organization (CMO) Business (2019-2024)
11.14.5 Patheon Recent Developments
11.15 Porton Pharma Solutions
11.15.1 Porton Pharma Solutions Company Details
11.15.2 Porton Pharma Solutions Business Overview
11.15.3 Porton Pharma Solutions Contract Bio-manufacturing Organization (CMO) Introduction
11.15.4 Porton Pharma Solutions Revenue in Contract Bio-manufacturing Organization (CMO) Business (2019-2024)
11.15.5 Porton Pharma Solutions Recent Developments
11.16 Probiogen
11.16.1 Probiogen Company Details
11.16.2 Probiogen Business Overview
11.16.3 Probiogen Contract Bio-manufacturing Organization (CMO) Introduction
11.16.4 Probiogen Revenue in Contract Bio-manufacturing Organization (CMO) Business (2019-2024)
11.16.5 Probiogen Recent Developments
11.17 Rader
11.17.1 Rader Company Details
11.17.2 Rader Business Overview
11.17.3 Rader Contract Bio-manufacturing Organization (CMO) Introduction
11.17.4 Rader Revenue in Contract Bio-manufacturing Organization (CMO) Business (2019-2024)
11.17.5 Rader Recent Developments
11.18 Rentschler Biotechnologie
11.18.1 Rentschler Biotechnologie Company Details
11.18.2 Rentschler Biotechnologie Business Overview
11.18.3 Rentschler Biotechnologie Contract Bio-manufacturing Organization (CMO) Introduction
11.18.4 Rentschler Biotechnologie Revenue in Contract Bio-manufacturing Organization (CMO) Business (2019-2024)
11.18.5 Rentschler Biotechnologie Recent Developments
11.19 Samsung
11.19.1 Samsung Company Details
11.19.2 Samsung Business Overview
11.19.3 Samsung Contract Bio-manufacturing Organization (CMO) Introduction
11.19.4 Samsung Revenue in Contract Bio-manufacturing Organization (CMO) Business (2019-2024)
11.19.5 Samsung Recent Developments
11.20 Sandoz
11.20.1 Sandoz Company Details
11.20.2 Sandoz Business Overview
11.20.3 Sandoz Contract Bio-manufacturing Organization (CMO) Introduction
11.20.4 Sandoz Revenue in Contract Bio-manufacturing Organization (CMO) Business (2019-2024)
11.20.5 Sandoz Recent Developments
11.21 STA Pharmaceutical Co. Ltd
11.21.1 STA Pharmaceutical Co. Ltd Company Details
11.21.2 STA Pharmaceutical Co. Ltd Business Overview
11.21.3 STA Pharmaceutical Co. Ltd Contract Bio-manufacturing Organization (CMO) Introduction
11.21.4 STA Pharmaceutical Co. Ltd Revenue in Contract Bio-manufacturing Organization (CMO) Business (2019-2024)
11.21.5 STA Pharmaceutical Co. Ltd Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Abzena
Althea
Asymchem Laboratories Inc.
Baxter Biopharma Solutions
Biomeva
Boehringer Ingelheim
Celltrion
AGC Biologics
Cytovance Biologics
Fujifilm Diosynth Technologies
KBI Biopharma
Lonza Group
MicroProtein Technologies
Patheon
Porton Pharma Solutions
Probiogen
Rader
Rentschler Biotechnologie
Samsung
Sandoz
STA Pharmaceutical Co. Ltd
?
?
*If Applicable.
